FDA Inspection 714035 — Ther-RX Corporation
The FDA completed an inspection of Ther-RX Corporation on Mar 11, 2011 in Chesterfield, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 11, 2011
- Fiscal Year
- 2011
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Chesterfield, MO (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)